Folic acid STADA 5 mg tablets, 100 pcs

Instructions for use for Folic acid STADA 5 mg tablets, 100 pcs

Important notes (compulsory information):

Folic acid STADA 5 mg tablets. Active substance: folic acid. Areas of application: For the treatment of folic acid substances that can not be remedied dieting.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


Instructions for use: Information for users

Folic acid stada 5 mg tablets
Active substance: folic acid

Read all of the use information carefully before you start using this medicine because it contains important information for you. Always take this medicine as described in this document information or just as your doctor or pharmacist is directed.

• Lift the use information. You might want to read it again.
• Ask your pharmacist if you need more information or advice.
• If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not specified in this information information. See section 4.
• If you do not feel better or even worse, contact your doctor.

What is in this information information:

1. What is folic acid STADA And what is it used for?
2. What should you before taking folic acid STADA NOTE?
3. What is folic acid STADA To take?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. What is folic acid STADA To keep?
6. Content of the pack and more information

1. What is folic acid STADA And what is it used for?

Folic acid STADA is a vitamin preparation for the treatment of folic acid substances. Folic acid stada is used for the treatment of folic acid substances which can not be remedied dieting.

2. What should you before taking folic acid STADA NOTE?

Folic acid STADA must not be taken if they are allergic to folic acid or one of the other ingredients of this medicine referred to in section 6. The folic acid caused increase in young red blood cells (Retikulocytes) can mask a vitamin B12 deficiency. Due to the risk of irreversible neurological disorders, it is important to ensure an anemia as a result of severely severe development of red blood cells (megaloblast anemia) that it is not based on a vitamin B12 deficiency. The cause of a megaloblast anemia must be clarified before the beginning of the therapy.

Warnings and Precautions:
Even with life-threatening megaloblast anemia, a possible vitamin B12 deficiency must be excluded because of the danger of permanent damage of the nervous system before the start of therapy (Ensuring serum and erythrocyte samples and determination of the vitamin B12 content).

Application of folic acid STADA together with other medicines:
Inform your doctor or pharmacist if you apply other medicines, recently applied other medicines or intend to apply other medicines. The administration of folic acid can the blood levels of funds against seizures (AntiConvulsants, e.g. Phenytoin, Phenobarbital, Primidon) reduce and thereby u. U. increase the canvastics. At administration of high doses can not be ruled out that folic acid stada and at the same time administered inhibitors of folic acid (Folic acid antagonists), e.g. Certain drugs against bacterial infections or malaria (trimethoprim, proguanil, pyrimethamine) and methotrexate (active ingredient and a. A. For the treatment of tumors), inhibit mutually in their effect. With simultaneous use with fluorouracil (medicines for the treatment of tumors), severe diarrhea can occur. Chloramphenicol (Drug for the treatment of infections) can prevent the response to the treatment with folic acid STADA and should therefore not be administered to patients with severe folic acid level symptoms.

Taking of folic acid stada together with food and beverages:
Take folic acid stada at meals.

Pregnancy and breast feeding period:
If you are pregnant or breastfeeding, or if you suspect to be pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before applying this medicine. There are no risks known.

Driving and ability to operate machines:
Effects on the ability to drive and the use of machines has not yet become known.

Folic acid STADA contains lactose:
Please include folic acid STADA only after consulting your doctor if you are familiar with any intolerance to certain sugars.

3. How is folic acid STADA To take?

Always take this medicine exactly as described in this document information or just according to the agreement made with your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure.

The recommended dose is:
Depending on requirements 1 to 3 tablets per day (corresponding to 5-15 mg folic acid).

Type of application:
The tablets are unadarved to meals with sufficient fluid (e.g., 1 glass of water.

Duration of application:
The duration of the treatment depends on the extent of the folic acid interface and depends on the clinical image and, if applicable, according to the corresponding laboratory diagnostic measured variables and is determined by the doctor for each patient. Please talk to your doctor if you have the impression that the effect of folic acid STADA is too strong or too weak.

If you take a greater amount of folic acid Stada than you should:
With occasional higher dosage, no overdose phenomena are to be expected. However, in patients with disappointment, it can lead to an increase in convulsiveness. At high dosages (over 15 mg per day and more than 4 weeks), gastrointestinal disorders (e.g. Bitter taste, loss of appetite, nausea, flatulence), Sleep disorders, excitement and depression occur. In these cases, you should contact your doctor.

If you forget to take folic acid STADA:
If you forget a tablet once, take the next tablet folic acid stada as usual. It is not necessary to subsequently take a forgotten tablet.

If you stop taking folic acid STADA:
If folic acid STADA has been prescribed, you should stop treatment only after consulting your doctor. If you have further questions about the application of this medicine, contact your doctor or pharmacist.

4. Which side effects are possible?

Like all medicines, this medicine can also have side effects, but they do not have to occur each other.

Rarely (can concern up to 1,000 treated):
Gastrointestinal disorders at high doses.
Sleep disorders, excitement and depression at high doses.

Very rare (can concern up to 1 treated by 10,000):
Inconstruction reactions, e.g. Haufförungen (erythema), itching (Pruritus), air not (bronchospasm), nausea or circulatory collapse (anaphylactic shock).

Message of side effects:
If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not indicated in this leaflet. You can also effectively effect the Federal Institute for Medicines and Medical Devices, Dept. Pharmacovigilance, Kurt-Georg-Kiesinger Allee 3, D-53175 Bonn, website: www.bfarm.de. By reporting side effects, you can help to provide more information about the security of this medicine.

5. How is folic acid STADA To keep?

Keep this medicine inaccessible to children. You must not use the medicinal product after the expiration date specified on the folding box and the blister pack. The expiration date refers to the last day of the specified month. Store in the original packaging to protect the content from light and moisture. Do not dispose of medicinest in wastewater or household waste. Ask your pharmacist how to dispose of the medicine if you do not use it anymore. You help to protect our environment.

6. Content of the pack and further information

As for folic acid stada:
The active ingredient is: folic acid. 1 tablet contains 5 mg of folic acid. The other ingredients are: cellulose powder, lactose monohydrate, magnesium stearate (ph.eur.), Hochdiserses silicon dioxide, talc.

Like folic acid stada looks and content of the pack:
Yellow to orange gel, round tablet. Folic acid STADA 5 mg is available in packs of 20, 50 and 100 tablets.

Admission holder:
Stadapharm GmbH
Stadastraße 2-18
61118 Bad Vilbel
www.stada.de

Distribution:
Stadavita GmbH
Königsteiner Straße 2
61350 Bad Homburg v.D.H.
www.stadavita.de

Manufacturer:
Stada medicine AG
Stadastraße 2-18
61118 Bad Vilbel

This information information was last revised in June 2014.

Source: Information of the leaflet
Status: 04/2017